STRENDENZ
LIVE

Serial Number

79397835

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

STRENDENZ Trademark

Serial Number: 79397835 • Registration: 7656778

STRENDENZ is a trademark filed by NOVARTIS AG on March 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 15, 2024

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 5, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 19, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 19, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 23, 2025 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Aug 7, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 7, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
REFUSAL PROCESSED BY IB
Oct 19, 2024 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 14, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 1, 2024 RFCS
REFUSAL PROCESSED BY MPU
Oct 1, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 26, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 25, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 25, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 30, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 30, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 30, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 30, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 30, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Jul 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 27, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 20, 2024 REPR